Matthew Kaplan

Stock Analyst at Ladenburg Thalmann

(3.83)
# 859
Out of 4,479 analysts
20
Total ratings
63.16%
Success rate
6.4%
Average return

12 Stocks

UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48$54
Current: $16.48
Upside: +224.64%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39$40
Current: $18.15
Upside: +120.39%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15$30
Current: $12.04
Upside: +149.17%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5$8.5
Current: $7.57
Upside: +12.29%
United Therapeutics
Aug 3, 2023
Maintains: Buy
Price Target: $256$268
Current: $319.01
Upside: -15.99%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15$16
Current: $14.12
Upside: +13.31%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $4.35
Upside: +24,520.69%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17$23
Current: $0.64
Upside: +3,515.78%
Reneo Pharmaceuticals
Nov 22, 2021
Initiates: Buy
Price Target: n/a
Current: $1.55
Upside: -
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: n/a
Current: $7.72
Upside: -
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: n/a
Current: $8.94
Upside: -
Protara Therapeutics
Jan 22, 2020
Initiates: Buy
Price Target: n/a
Current: $2.09
Upside: -